Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Saved in:
| Title: | Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. |
|---|---|
| Authors: | Pipe SW; University of Michigan, Ann Arbor, Michigan, USA., Hermans C; Cliniques Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Chitlur M; Children's Hospital of Michigan, Central Michigan University, Detroit, Michigan, USA., Carcao M; The Hospital for Sick Children, Toronto, Ontario, Canada., Castaman G; Center for Bleeding Disorders and Coagulation, Careggi University Hospital, Florence, Italy., Davis JA; Pediatric Hemophilia Treatment Center, University of Miami, Miami, Florida, USA., Ducore J; Hematology/Oncology Clinic, University of California at Davis, Sacramento, California, USA., Dunn AL; Nationwide Children's Hospital, Department of Pediatrics at The Ohio State University College of Medicine, Columbus, Ohio, USA., Escobar M; University of Texas Health Science Center at Houston, Houston, Texas, USA., Journeycake J; Oklahoma Center for Bleeding and Clotting Disorders at OU Health, Oklahoma City, Oklahoma, USA., Khan O; Oklahoma Center for Bleeding and Clotting Disorders at OU Health, Oklahoma City, Oklahoma, USA., Mahlangu J; Hemophilia Comprehensive Care Center, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa., Meeks SL; Emory University and Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Mitha IH; Lakeview Hospital, Benoni, Gauteng, South Africa., Négrier C; Edouard Herriot University Hospital, Lyon, France., Nowak-Göttl U; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany., Recht M; American Thrombosis and Hemostasis Network, Rochester, New York, USA.; Oregon Health & Science University, Portland, Oregon, USA., Chrisentery-Singleton T; Louisiana Center for Advanced Medicine, Slidell, Louisiana, USA., Stasyshyn O; Institute of Blood Pathology and Transfusion Medicine, Lviv, Ukraine., Vilchevska KV; National Specialized Children's Hospital Okhmatdyt, Kyiv, Ukraine., Martinez LV; Dr. José Eleuterio González Monterrey University Hospital, Monterrey, Nuevo León, México., Wang M; Hemophilia and Thrombosis Center, University of Colorado, Aurora, Colorado, USA., Windyga J; Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Young G; Children's Hospital Los Angeles, Los Angeles, California, USA.; Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Alexander WA; Aoede Associates, Athens, Texas, USA., Bonzo D; LFB-USA, Inc., Framingham, Massachusetts, USA., Macie C; HEMA Biologics, LLC, Louisville, Kentucky, USA., Mitchell IS; HEMA Biologics, LLC, Louisville, Kentucky, USA., Sauty E; LFB, Laboratoire français du fractionnement et des biotechnologies, Les Ulis, France., Wilkinson TA; GLOVAL LLC, Broomfield, Colorado, USA., Shapiro AD; Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana, USA. |
| Source: | Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2022 Jul; Vol. 28 (4), pp. 548-556. Date of Electronic Publication: 2022 Apr 27. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Blackwell Science Country of Publication: England NLM ID: 9442916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2516 (Electronic) Linking ISSN: 13518216 NLM ISO Abbreviation: Haemophilia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2516 |
|---|---|
| DOI: | 10.1111/hae.14563 |
